AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionHutner Capital Management Inc
Latest Disclosed Ownership40,006 shares
Latest Disclosed Value $ 8,700,920
Hutner Capital Management Inc reports 4.46% decrease in ownership of ABBV / AbbVie Inc.

On May 15, 2026 - Hutner Capital Management Inc filed a 13F-HR form disclosing ownership of 40,006 shares of AbbVie Inc. (MX:ABBV) valued at $8,700,920 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 41,872 shares of AbbVie Inc.. This represents a change in shares of -4.46% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AbbVie COM 00287Y109 40,006 -1,866 -4.46 8,701 -9.06 3.5745
2026-02-17 2025-12-31 13F AbbVie COM 00287Y109 41,872 -248 -0.59 9,567 -1.90 3.9931
2025-11-13 2025-09-30 13F AbbVie COM 00287Y109 42,120 156 0.37 9,752 25.20 4.1254
2025-08-13 2025-06-30 13F AbbVie COM 00287Y109 41,964 -1,132 -2.63 7,789 -13.73 3.5431
2025-05-13 2025-03-31 13F AbbVie COM 00287Y109 43,096 693 1.63 9,030 19.83 3.8536
2025-02-14 2024-12-31 13F AbbVie COM 00287Y109 42,403 3,901 10.13 7,535 -0.89 3.6392
2024-11-13 2024-09-30 13F AbbVie COM 00287Y109 38,502 -63 -0.16 7,603 14.95 3.7848
2024-08-13 2024-06-30 13F AbbVie COM 00287Y109 38,565 -500 -1.28 6,615 -7.02 3.6267
2024-05-10 2024-03-31 13F AbbVie COM 00287Y109 39,065 7 0.02 7,114 17.53 3.8577
2024-02-14 2023-12-31 13F AbbVie COM 00287Y109 39,058 -832 -2.09 6,053 1.78 3.5672
2023-11-14 2023-09-30 13F AbbVie COM 00287Y109 39,890 -394 -0.98 5,946 9.56 3.6464
2023-08-14 2023-06-30 13F AbbVie COM 00287Y109 40,284 17 0.04 5,427 -15.43 3.1727
2023-05-15 2023-03-31 13F AbbVie COM 00287Y109 40,267 85 0.21 6,417 -1.17 3.9058
2023-02-14 2022-12-31 13F AbbVie COM 00287Y109 40,182 433 1.09 6,494 21.71 4.0222
2022-11-14 2022-09-30 13F AbbVie COM 00287Y109 39,749 91 0.23 5,335 -12.17 3.7307
2022-08-11 2022-06-30 13F AbbVie COM 00287Y109 39,658 -81 -0.20 6,074 -5.71 3.9852
2022-05-13 2022-03-31 13F AbbVie COM 00287Y109 39,739 -158 -0.40 6,442 19.25 3.6756
2022-02-11 2021-12-31 13F AbbVie COM 00287Y109 39,897 -395 -0.98 5,402 24.30 3.1539
2021-11-12 2021-09-30 13F AbbVie COM 00287Y109 40,292 186 0.46 4,346 -3.81 2.8438
2021-08-13 2021-06-30 13F AbbVie COM 00287Y109 40,106 -677 -1.66 4,518 2.36 2.8920
2021-05-18 2021-03-31 13F AbbVie COM 00287Y109 40,783 2,383 6.21 4,414 7.27 2.8949
2021-02-16 2020-12-31 13F AbbVie COM 00287Y109 38,400 86 0.22 4,115 22.62 2.8651
2020-11-13 2020-09-30 13F AbbVie COM 00287Y109 38,314 4,265 12.53 3,356 0.39 2.4939
2020-08-14 2020-06-30 13F AbbVie COM 00287Y109 34,049 9,256 37.33 3,343 76.97 2.8264
2020-05-13 2020-03-31 13F AbbVie COM 00287Y109 24,793 -50 -0.20 1,889 -14.14 1.7253
2020-01-30 2019-12-31 13F AbbVie COM 00287Y109 24,843 -210 -0.84 2,200 15.97 1.5162
2019-11-12 2019-09-30 13F AbbVie COM 00287Y109 25,053 0 0.00 1,897 4.12 1.3425
2019-08-07 2019-06-30 13F AbbVie COM 00287Y109 25,053 0 0.00 1,822 -9.76 1.2960
2019-05-10 2019-03-31 13F AbbVie COM 00287Y109 25,053 -942 -3.62 2,019 -15.73 1.4785
2019-02-12 2018-12-31 13F AbbVie COM 00287Y109 25,995 730 2.89 2,396 0.25 1.8699
2018-11-02 2018-09-30 13F AbbVie COM 00287Y109 25,265 0 0.00 2,390 2.09 1.7342
2018-07-06 2018-06-30 13F AbbVie COM 00287Y109 25,265 -520 -2.02 2,341 -4.10 1.8286
2018-04-06 2018-03-31 13F AbbVie COM 00287Y109 25,785 -50 -0.19 2,441 -2.32 1.9022
2018-01-31 2017-12-31 13F AbbVie COM 00287Y109 25,835 0 0.00 2,499 8.84 1.7813
2017-10-30 2017-09-30 13F AbbVie COM 00287Y109 25,835 0 0.00 2,296 22.58 1.7384
2017-08-11 2017-06-30 13F AbbVie COM 00287Y109 25,835 -485 -1.84 1,873 9.21 1.4440
2017-05-09 2017-03-31 13F AbbVie COM 00287Y109 26,320 -672 -2.49 1,715 1.48 1.3524
2017-02-15 2016-12-31 13F AbbVie COM 00287Y109 26,992 -1,350 -4.76 1,690 -5.48 1.4018
2016-11-14 2016-09-30 13F AbbVie COM 00287Y109 28,342 28,342 1,788 1.5176
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.